An assessment of the understanding and motivations of patients with schizophrenia about participating in a clinical trial

Contemporary Clinical Trials

Volumn 30, Issue 5, 2009, Pages 446-450

  Chong, Siow Ann ^a   Ong, Yuen Yeng ^a   Subramaniam, Mythily ^a   Abdin, Edimansyah ^a   Marx, Christine E ^b   Campbell, Alastair Vincent ^c  

^a INSTITUTE OF MENTAL HEALTH   (Singapore)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Clinical trial; Educational intervention; Enrollment; Motivations; Placebo; Randomization

Indexed keywords

NEUROLEPTIC AGENT; PLACEBO;

ADAPTATION; ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EDUCATION; EDUCATIONAL STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; OUTCOME ASSESSMENT; PERSONNEL SHORTAGE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCHIZOPHRENIA; TREATMENT DURATION; TREATMENT RESPONSE; ATTITUDE TO HEALTH; COMPREHENSION; CONFIDENCE INTERVAL; INFORMED CONSENT; PATIENT EDUCATION; PERCEPTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; SINGAPORE;

ADULT; ANTIPSYCHOTIC AGENTS; COMPREHENSION; CONFIDENCE INTERVALS; EDUCATIONAL MEASUREMENT; EDUCATIONAL STATUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMED CONSENT; MALE; MOTIVATION; ODDS RATIO; PATIENT EDUCATION AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHIZOPHRENIA; SINGAPORE; SOCIAL PERCEPTION;

EID: 68349121597     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2009.04.006     Document Type: Article

References (23)

1. Nathan R.A. How important is patient recruitment in performing clinical trials?. J Asthma 36 (1999) 213-216
2. Halpern S.D. Prospective preference assessment: a method to enhance the ethics and efficiency of randomized controlled trials. Control Clin Trials 23 (2002) 274-288
3. DeRenzo E.G., Conley R.R., and Love R.C. Assessment of capacity to give consent to research participation: State-of-the-art and beyond. J Health Care Law Policy 1 (1998) 66-87
4. Appelbaum P.S. Decisional capacity of patients with schizophrenia to consent to research: taking stock. Schizophr Bull 32 (2006) 22-25
5. Moser D.L., Reese R.L., Hey C.T., et al. Using a brief intervention to improve decisional capacity in schizophrenia research. Schizophr Bull 32 (2006) 116-120
6. Wilson S.T., and Stanley B. Ethical concerns in schizophrenia research: looking back and moving forward. Schizophr Bull 32 (2006) 30-36
7. Halpern S.D., Karlawish J.H., Casarett, et al. Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency. Am Heart J 146 (2003) 985-992
8. Creel A.H., Losina E., Mandl L.A., et al. An assessment of willingness to participate in a randomized trial of arthroscopic knee surgery in patients with osteoarthritis. Contemp Clin Trials 26 (2005) 169-178
9. Dunn L.B., Candilis P.J., and Robert L.W. Emerging empirical evidence on the ethics of schizophrenia research. Schizophr Bull 32 (2006) 47-68
10. Dunn L.B., Barton W.P., and Keehan. Understanding of placebo controls among older people with schizophrenia. Schizophr Bull 32 (2006) 137-146
11. Dunn L.B., Lindamer L.A., Palmer B.W., Schneiderman L.J., and Jeste D.V. Enhancing comprehension of consent for research in older patients with psychosis: a randomized study of a novel consent procedure. Am J Psychiatry 158 (2001) 1911-1913
12. Dunn L.B., and Jeste D.V. Enhancing informed consent for research and treatment. Neuropsychopharmacology 24 (2001) 595-607
13. Dunn L.B., Nowrangi M.A., Palmer B.W., Jeste D.V., and Saks E.R. Assessing decisional capacity for clinical research or treatment: a review of instruments. Am J Psychiatry 63 (2006) 1323-1334
14. Silva M.C., and Sorrell J.M. Enhancing comprehension of information for informed consent: a review of empirical research. IRB Ethics Human Res 10 (1988) 1-5
15. Roberts L.W., Warner T.D., and Brody J.L. Perspectives of schizophrenia patients and their psychiatrists regarding ethically important aspects of research participation. Am J Psychiatry 157 (2000) 67-74
16. Roberts L.W., and Poberts B. Psychiatric research ethics: an overview of evolving guidelines and current ethical dilemmas in the study of mental illness. Biol Psychiatry 46 (1999) 1025-1038
17. Bently J., and Thacker P. The influence of risk and monetary payment on the research decision making process. J Med Ethics 30 (2004) 293-298
18. Marson D.C., Savage R., and Philips J. Financial capacity in persons with schizophrenia and serious mental illness: clinical and research ethics aspects. Schizophr Bull 32 (2006) 81-91
19. Marson D., Sawrie S., Snyder S., et al. Assessing financial capacity in patients with Alzheimer disease. Arch Neurol 57 (2000) 877-884
20. Dickert N., and Grady C. What's the price of a research subject?. N Eng J Med 341 (1999) 198-203
21. Appelbaum P.S., Roth L.H., Lidz C.W., Benson P., and Winslade W. False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep 17 (1987) 20-24
22. Dresser R. Mentally disabled research subjects. The enduring policy issues. JAMA 276 (1996) 67-72
23. Roberts L.W., Lauriello J., Geppert C., and Keith S.J. Placebos and paradoxes in psychiatric research: an ethics perspective. Biol Psyschiatry 49 (2001) 887-893